Waverly Advisors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
Waverly Advisors's RGEN Position: Q2 2026 in Review
Waverly Advisors increased its Repligen (RGEN) stake by 10% in Q2 2026, buying an estimated $370K and bringing the position to 32,751 shares worth $4.47M. The position accounts for 0.03% of the portfolio, ranked #479.
Waverly Advisors first reported a position in RGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $5.05M in Q4 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- Waverly Advisors held 32,751 shares of Repligen worth $4.47M as of Q2 2026.
- Waverly Advisors bought 3,009 Repligen shares in Q2 2026, an estimated $370K.
- Repligen made up 0.03% of Waverly Advisors's portfolio in Q2 2026, its #479 holding.
- Waverly Advisors first reported a position in Repligen in Q1 2025 and has held it in 6 quarters since.
- Waverly Advisors's Repligen position peaked at $5.05M in Q4 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on Waverly Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.